Skip to content

Postoperative Rehabilitation of Non-Small Cell Lung Cancer Based on Wireless Wearable Mobile Monitoring Devices

Postoperative Rehabilitation of Non-Small Cell Lung Cancer Based on Wireless Wearable Mobile Monitoring Devices

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117019
Enrollment
Unknown
Registered
2026-01-19
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer, NSCLC

Interventions

Intervention Group :Standard Perioperative Treatment Combined with Wearable Device-Assisted Perioperative Rehabilitation
Control Group:Conventional perioperative pathway management without additional rehabilitation platforms or prehabilitation interventions.

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1) Aged >=18 years and <=85 years. 2) Diagnosed with primary non-small cell lung cancer (NSCLC) confirmed by histopathology, and having completed elective radical lobectomy or segmentectomy. 3) Scheduled for discharge between postoperative days 2 and 7, with the investigator judging the patient’s condition to be stable and suitable for participation in this clinical study. 4) Able to operate smartphone applications and wearable devices independently or with the assistance of a caregiver. 5) Voluntarily agrees to participate in the study and has signed a written informed consent form.

Exclusion criteria

Exclusion criteria: 1) Long-term home oxygen therapy prior to surgery, or the presence of severe resting respiratory dysfunction, or coexisting severe cardiopulmonary diseases. 2) Coexisting severe, uncontrolled cardiovascular or cerebrovascular diseases, hepatic insufficiency, or renal insufficiency. 3) Presence of other diseases that severely affect motor function or compliance. 4) Known or suspected history of contact allergy to the medical adhesive or materials used in the wearable devices. 5) Any other condition considered by the investigator to be unsuitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
FEV1/FVC;Between-group differences in lung function at 30 days versus three months after surgery;

Secondary

MeasureTime frame
The six-minute walk test;Pulmonary function;Perioperative indicators;Feedback from patients;Compliance with the platform;

Countries

China

Contacts

Public ContactHu Liao

West China Hospital of Sichuan University

drliaohu@scu.edu.cn+86 189 8060 5130

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026